Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Evaluating credit card rewards is crucial for maximizing value. Learn which options provide the best returns for your spending.
28,180 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Companies are ditching token-based performance dashboards as ROI from AI pivots to concrete business outcomes like re...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
Bitwise argues that investors have not fully priced Hyperliquid's expansion into a multi-asset platform and the value...
Retail traders on Robinhood are flocking to a high-yield FANG income ETF, chasing monthly payouts even as upside is c...
Analysts stage a fresh look at Tesla’s 2027 price target, signaling a measured path ahead as product rollouts and cas...
July began with AI-driven headlines shifting attention from headlines to execution. This guide breaks down how stock ...
SpaceX has joined the NASDAQ 100, but veteran skepticism remains. Famed investor jeremy gratham says today’s hype cou...
As geopolitical tensions rise, investors reassess defense exposure. This report examines the weapons that changed war...
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
Pershing Square’s bill ackman been quietly building a Microsoft stake since February signals a patient, long-term bet...
As Berkshire Hathaway marks decades of outperformance, Warren Buffett remains adamant that most investors should own ...